Register Login

PMV PHARMACEUTICALS, INC. (PMVP)

(85% Positive) PMV PHARMACEUTICALS, INC. (PMVP) Announces Enrollment Update for conference Due to Geopolitical Situation, Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot Aug. 31, 2026, 8:08 p.m.

    📋 PMV PHARMACEUTICALS, INC. (PMVP) - Clinical Trial Update

    Filing Date: 2026-08-31

    Accepted: 2026-08-31 16:06:01

    Event Type: Clinical Trial Update

    Event Details:

    PMV PHARMACEUTICALS, INC. (PMVP) Announces Clinical Trial Update PMV PHARMACEUTICALS, INC. (PMVP) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: conference, daily
    • Clinical Stage: Pivotal Trial, Phase 2
    • Collaboration: FDA
      • targeting p53. TP53 mutations are found in approximately half of all cancers. Our co-founder, Dr. Arnold Levine, established the field of p53 biology when he discovered the p53 protein in 1979
      • targeting p53, today announced updated interim ovarian cancer data from the Phase 2 pivotal portion of the PYNNACLE clinical trial. The multicenter, single-arm, registrational Phase 2 trial is assessing rezatapopt as monotherapy at a dose of 2000

    🔬 Clinical Development Pipeline (PMV PHARMACEUTICALS, INC.):

    Product Type Development Stage Therapeutic Area Source
    PC14586 Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Rezatapopt Other Phase PHASE1 Myelodysplastic Syndrome ClinicalTrials.gov
    Azacitidine Other Phase PHASE1 Myelodysplastic Syndrome ClinicalTrials.gov
    midazolam hydrochloride syrup Other Phase PHASE1 TP53 Y220C Mutation ClinicalTrials.gov
    repaglinide 0.5 mg tablet Other Phase PHASE1 TP53 Y220C Mutation ClinicalTrials.gov
    rosuvastatin 10 mg tablet Other Phase PHASE1 TP53 Y220C Mutation ClinicalTrials.gov
    metformin hydrochloride 500 mg tablet Other Phase PHASE1 TP53 Y220C Mutation ClinicalTrials.gov
    pembrolizumab Other Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    [14C]-PC14586 Other Phase PHASE1 Healthy Male Volunteers ClinicalTrials.gov
    Itraconazole Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Famotidine Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    Rabeprazole Other Phase PHASE1 Healthy Volunteers ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: PMV PHARMACEUTICALS, INC.
    • Ticker Symbol: PMVP

Search

News categories